PPT-COVID-19 vaccines Regulatory Status Update 25 January 2021 Dr B Semete-Makokotlela SAHPRA

25 January 2021 Dr B SemeteMakokotlela SAHPRA CEO Vaccine applications submitted to SAHPRA Vaccine developer Name Regulatory status outside SA Application at SAHPRA Status at SAHPRA Janssen. November 6, 2013. at the Frederik Meijer Gardens & Sculpture Park. 2014. CEO Strategies. Your 2014 Board of Directors.... 2. Linda . Bodie. Dean . Wilson. Don . Mills. Jeff. Jorgensen. Scott. McFarland. WHO Technical Briefing Seminar on Essential Medicines and Health Products. 31 October 2013. WHO Headquarters, Geneva, Salle M 505. Dr Claudia P Alfonso . Outline. Global overview of vaccine production and immunization . on following dates in 2021 July 2021 There will be supplementary data update when IEF receives additional data submissions after those update dates above The completion of each Among Your Patients. Tips for the Healthcare Team. Developed by:. CDC COVID-19 Response . Vaccine Task Force. January 2021. Presentation Overview. COVID-19 vaccines. mRNA vaccine technology. Vaccine safety monitoring. Information current as of . 4/1/2021. There are . three COVID-19 . vaccines currently authorized and recommended for use in the United States, . and . other . vaccines are currently in large-scale clinical trials. . September 16, 2021. COVID-19 Vaccination Clinical Considerations. Key points: Interim clinical considerations for COVID-19 vaccines. 2. COVID-19 vaccination is recommended for all people 12 years and older.. 12/15/2021. Today’s Speaker. Gregory Schrank, MD MPH. Dr. Greg Schrank attended medical school at the Lewis Katz School of Medicine at Temple University in Philadelphia. He went on to complete Internal Medicine residency training at the NYU School of Medicine, where he also served as a chief medical resident, followed by a fellowship in Infectious Diseases at Beth Israel Deaconess Medical Center/Harvard Medical School. While there, he completed additional fellowship training in infection control and hospital epidemiology. After fellowship, Dr. Schrank joined the faculty at the University of Maryland School of Medicine as an Assistant Professor of Medicine in the Division of Infectious Diseases. He sees patients at the R Adams Cowley Shock Trauma Center and serves as an Associate Hospital Epidemiologist for the University of Maryland Medical Center. During the COVID-19 pandemic, he served as an Incident Commander for the COVID-19 response at the University of Maryland Medical Center during the Spring and Fall surges of 2020 and more recently as a subject matter expert for University of Maryland Medical System’s vaccination efforts. COVID-19 Vaccine Information. for Partner Communities. February 2021. COVID-19 and . Vaccine Basics. What we know about. Coronavirus Disease 2019. (COVID-19). COVID-19 is an illness caused by a coronavirus. This coronavirus is a new virus that was first recognized December 2019 in Wuhan, China. These are a large family of viruses, some of which infect animals, and others that can infect humans.. DNA vaccine is DNA sequence used as a vaccine.. This DNA Sequence code for antigenic protein of pathogen.. As this DNA inserted into cells it is translated to form antigenic protein. As this protein is foreign to cells, so immune response raised against this protein.. April 6, 2022. Notable vaccine mandate decisions from the . Supreme Court of the United States. Jacobson v. Massachusetts. , 197 U.S. 11 (1905).. States . have. police power to mandate vaccination.. Name Here, followed by credentials. Slides adapted from Centers for Disease Control and Prevention and the Oregon Health Authority . . | page . 2. About me. Add info here. Add info here.. Add info here.. A presentation for Staff and residents in post-acute and Long-Term Care. Michael R. Wasserman, MD, CMD. Immediate Past President, CALTCM. January 6, 2021. Special thanks to:. Dr. Leslie Eber, AMDA, and the CALTCM Vaccine Delphi Group. 03 February 2021. Dr B Semete. Contents. COVID-19 vaccines. Ivermectin. access program. Summary of the most advanced vaccines in development. Vaccine applications submitted to SAHPRA. Vaccine developer. Disclosure. . This presentation has been created using the . CDC’s COVID-19 Vaccine Information for Community-Based Organizations. , as well as information included in the CDC’s frequently asked questions section. The sources will be included at the end of this presentation. .